FOR IMMEDIATE RELEASE: UNITED STATES PATENT OFFICE GRANTS PATENT LICENSE and APPROVAL for FOREIGN PATENT FILINGS.

September 18, 2004 -- BIOSYSTEMS has induced stem cells into becoming viable nerve cells with complete myelin sheaths or nerve protectors that then proliferate,ultimately providing renewed nerve endings, and connections resulting in both improved mobility and dexterity in most instances.

What was truly unexpected is that long term spinal cord injuries also benefit from the company's patent license procedure.

The United States patent and Trademark Office granted BIOSYSTEMS, a patent license for its stem cell therapy treatment procedure for most spinal cord injuries.

This patent license will allow the company to present and make available its patented procedures to those individuals who have spinal cord injuries.

BIOSYSTEMS has long supported and endoresed the California Stem Cell Initiative for Cures efforts which supporting stem cell research in all areas to include the area of stem cell treatment for spinal cord injuries.

The Company's on-going research will continue to improve upon the patented stem cell therapy treatment for spinal cord injuries.

For additional information contact: Dr. Richard Harmon-Director-Press Relations, at:(310) 428-0888. Email:greeassoc@aol.com

BIOSYSTEMS, INC. is a devleopment stage corporation, incorporated in the State of California. The company has license arrangments for several stem cell therapy treatements to include Juvenile Diabetes, Tay-Sachs, Sickle cell anemia, and Leukemia.

CONTACT INFORMATION:
Robert Bolt-Director
BIOSYSTEMS, INC.
310-428-0888
http://www.BIOSYSTEMSINC.org



This article courtesy of http://patent101.com.
You may freely reprint this article on your website or in
your newsletter provided this courtesy notice and the author
name and URL remain intact.

Submit Your Article